Skip to main content
Premium Trial:

Request an Annual Quote

Whatman Terminates S&S s IsoCode License as Part of Patent Infringement Settlement

NEW YORK, July 13 (GenomeWeb News) - Whatman said today that it has terminated a licensing deal with Schleicher & Schuell as part of a settlement agreement for a patent infringement lawsuit related to Whatman's FTA DNA isolation technology.

 

Whatman said it initiated the lawsuit in the United States in 2003 "to stop S&S exceeding the terms of the license that had been granted to S&S for the manufacture and sale of a product based on Whatman's FTA technology." Whatman said today that it has negotiated "the termination of the license altogether," and acquired some further patents related to S&S's DNA related technology.

 

Under the terms of the settlement, Whatman has terminated a license agreement under which S&S was selling its IsoCode DNA storage products and has acquired some patents related to S&S's IsoCode technology. S&S will continue to supply the IsoCode products "for a transitional period," to a "limited number" of existing customers," Whatman said.

 

Whatman said it will also pay S&S $500,000 under the settlement agreement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.